|
|
|
|
LEADER |
01319caa a2200373 ir4500 |
001 |
NSK01000039206 |
003 |
HR-ZaNSK |
005 |
20070917095534.0 |
008 |
940302s1993 ci ||| ||eng |
015 |
|
|
|a HP93-5243
|2 HR
|
035 |
|
|
|9 (HR-ZaNSK)39244
|
035 |
|
|
|9 (HR-ZaNSK)940302105
|
035 |
|
|
|a (HR-ZaNSK)000039206
|
040 |
|
|
|a HR-ZaNSK
|b hrv
|c HR-ZaNSK
|e ppiak
|
041 |
0 |
|
|a eng
|b hrv
|
080 |
|
|
|a 618.19-006-085
|
100 |
1 |
|
|a Jereczek-Fossa, Barbara Alicja
|
245 |
1 |
0 |
|a Low weekly doses of doxorubicin and epidoxorubicin in second line chemotherapy of advanced breast cancer /
|c Barbara Jereczek, Jacek Jassem, Hanna Karnicka-Mlodkowska, Jerzy Tujakowski, Jerzy Zaluski, Krystyna Moszkowska-Kopij, Iwona Zander and Ewa Solska.
|
300 |
|
|
|b Ilustr.
|
504 |
|
|
|a Bibliografija: 18 jed.
|
504 |
|
|
|a Summary
|
650 |
|
7 |
|a Dojka
|x Karcinom
|x Farmakoterapija
|2 nskps
|
700 |
1 |
|
|a Jassem, Jacek
|
700 |
1 |
|
|a Karnicka-Mlodkowska, Hanna
|
700 |
1 |
|
|a Tujakowski, Jerzy
|
700 |
1 |
|
|a Zaluski, Jerzy
|
700 |
1 |
|
|a Moszkowska-Kopij, Krystyna
|
700 |
1 |
|
|a Zander, Iwona
|
700 |
1 |
|
|a Solska, Ewa
|
773 |
0 |
|
|t Libri oncologici
|x 0300-8142
|g 22 (1993), 3 ; str. 213-218
|w nsk.(HR-ZaNSK)000011357
|
932 |
|
|
|a da
|b znanstveni rad
|
981 |
|
|
|p CRO
|
998 |
|
|
|c sbni9902
|
886 |
0 |
|
|2 unimarc
|b 01126naa2 2200289 450
|